# Study of Quality of Life and Hormone Levels in Premenopausal Participants With Early Breast Cancer Receiving Triptorelin Plus Additional Cancer Treatment

> **NCT05377684** · — · ACTIVE_NOT_RECRUITING · sponsor: **Ipsen** · enrollment: 450 (actual)

## Conditions studied

- Early-stage Breast Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05377684
- **Lead sponsor:** Ipsen
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-06-09
- **Primary completion:** 2026-06-05
- **Final completion:** 2026-06-05
- **Target enrollment:** 450 (ACTUAL)
- **Last updated:** 2026-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05377684

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05377684, "Study of Quality of Life and Hormone Levels in Premenopausal Participants With Early Breast Cancer Receiving Triptorelin Plus Additional Cancer Treatment". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05377684. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*